← All trials
NCT02457273
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2015
- Primary completion
- Dec 1, 2018
- Completion date
- Dec 1, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 44
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Government of TaiwanLead sponsor
- Taichung Veterans General HospitalOverall official - principal investigator
- Chang Gung UniversityOverall official - principal investigator
- Taichung Veterans General HospitalCollaborator
- National Taiwan UniversityCollaborator
- Chang Gung UniversityCollaborator
- National Cheng Kung UniversityOverall official - principal investigator
- National Cheng Kung UniversityCollaborator
- Taipei Veteran General hospitalStudy director
- Taipei Veteran General hospitalStudy chair
- Taipei Veteran General hospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.